GlassScriptPhysician profile
Joji Joseph
NPI 1568099224
$1,541.79
in general payments reported to CMS, 2019-2025
11 companies · $840 in 2025
The $840 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $701 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.81 |
| Education | $196.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $472.24 | 2024-2025 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $271.87 | 2024-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.07 | 2024-2025 | Ofev, Jascayd |
| Genzyme Corporation | $190.32 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $140.92 | 2024-2025 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $97.99 | 2025 | |
| United Therapeutics Corporation | $67.23 | 2024-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $32.42 | 2025 | Arikayce |
| Gilead Sciences, INC. | $28.08 | 2024 | Vemlidy |
| Mylan Specialty L.P. | $19.50 | 2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $17.15 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joji Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.